相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study
Teerha Piratvisuth et al.
HEPATOLOGY COMMUNICATIONS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Bishuang Cai et al.
CELL METABOLISM (2020)
Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer
Jianjun Qi et al.
CELL DEATH & DISEASE (2020)
MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation
Chihiro Nishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
Mirella Pastore et al.
FRONTIERS IN PHARMACOLOGY (2019)
MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
Evangelos Triantafyllou et al.
GUT (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
Nellie K. McDaniel et al.
MOLECULAR CANCER THERAPEUTICS (2018)
MerTK is a novel therapeutic target in gastric cancer
Jun Ho Yi et al.
ONCOTARGET (2017)
Genetic prevention of hepatitis C virus-induced liver fibrosis by allele-specific downregulation of MERTK
Marco Cavalli et al.
HEPATOLOGY RESEARCH (2017)
Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2
Kevin Brown Chandler et al.
JOURNAL OF PROTEOME RESEARCH (2017)
Role of N-glycosylation in EGFR ectodomain ligand binding
Maryam Azimzadeh Irani et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2017)
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease
Salvatore Petta et al.
JOURNAL OF HEPATOLOGY (2016)
MERTK as a novel therapeutic target in head and neck cancer
Anne von Maessenhausen et al.
ONCOTARGET (2016)
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
Marka R. Crittenden et al.
ONCOTARGET (2016)
Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics
Deyao Xie et al.
ONCOTARGET (2016)
In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation
Manveen K. Sethi et al.
GLYCOBIOLOGY (2015)
Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition
Hsin-Yung Yen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS)
Sarah Krause et al.
BLOOD (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
Khanh-Quynh N. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
S. Ammoun et al.
ONCOGENE (2014)
Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer
Yongzhang Liu et al.
ONCOTARGET (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Molecular Pathways: MERTK Signaling in Cancer
Christopher T. Cummings et al.
CLINICAL CANCER RESEARCH (2013)
c-Met function requires n-linked glycosylation modification of pro-Met
Run Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
Jennifer Schlegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
R. M. A. Linger et al.
ONCOGENE (2013)
Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus
Justine Migdall-Wilson et al.
PLOS ONE (2012)
Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
Jessica E. Brown et al.
PLOS ONE (2012)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Recombinant Mouse Granulocyte-Macrophage Colony-Stimulating Factor Is Glycosylated in Transgenic Tobacco and Maintains its Biological Activity
Anna Gora-Sochacka et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells
Joseph N. Contessa et al.
CANCER RESEARCH (2008)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia
DK Graham et al.
CLINICAL CANCER RESEARCH (2006)
Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM
A Kazui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
